Successful evolution of morphea after hepatitis C virus eradication with direct-acting antiviral agent treatment

Rev Esp Enferm Dig. 2019 Dec;111(12):973. doi: 10.17235/reed.2019.6461/2019.

Abstract

Hepatitis C virus infection has been associated with many dermatologic conditions such as lichen planus, porphyria cutanea tarda, and cryoglobulinemia. Recently, an association of HCV with systemic sclerosis has been reported. However, there are few reports of the association of localized scleroderma or morphea with Hepatitis C Virus infection. We describe the case of a 36 years old female patient suffering from prolonged morphea with difficult management, who was recently diagnosed of Hepatitis C Virus and received direct-acting antiviral agents treatment with Hepatitis C Virus clearance. Skin lesion faded away in a short period after successful therapy.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use*
  • Benzimidazoles / therapeutic use*
  • Female
  • Fluorenes / therapeutic use*
  • Hepacivirus / genetics
  • Hepatitis C / complications
  • Hepatitis C / drug therapy*
  • Humans
  • Scleroderma, Localized / drug therapy*
  • Scleroderma, Localized / etiology
  • Sofosbuvir
  • Thigh
  • Uridine Monophosphate / analogs & derivatives*
  • Uridine Monophosphate / therapeutic use

Substances

  • Antiviral Agents
  • Benzimidazoles
  • Fluorenes
  • ledipasvir, sofosbuvir drug combination
  • Uridine Monophosphate
  • Sofosbuvir